Benevolent Platform
The facts below are what the maker publishes about Benevolent Platform, checked and dated. Our editors have not written about it yet.
The facts
Each one read from Benevolent Platform's own pages, with the date it was checked.
What it does
- AI and data
- BenevolentAI describes its technology as using multimodal data to surface insights and accelerate biomedical discovery.checked 14 Nov 2026
- Audience
- BenevolentAI says its team supports scientists and executives using AI and machine learning in their work.checked 14 Nov 2026
- Collaborations
- The company names AstraZeneca and Merck among its pharmaceutical discovery collaboration partners.checked 14 Nov 2026
- Contact
- The company provides a press contact email address.checked 14 Nov 2026
- Drug discovery
- The company says it uses its platform, scientific expertise, and wet-lab facilities to accelerate novel drug discovery.checked 14 Nov 2026
- Focus
- In April 2024, BenevolentAI said it would focus on drug discovery collaborations and its proprietary pipeline.checked 14 Nov 2026
- Knowledge Exploration Tools
- The company announced that work on its Knowledge Exploration Tools would cease after a market assessment.checked 14 Nov 2026
- Knowledge graph
- The company says its technology builds on investment in a knowledge graph and proprietary ontologies.checked 14 Nov 2026
- Product availability
- The current homepage presents Qor as an always-on strategic function for biopharma decision makers and life science consultancies.checked 14 Nov 2026
The company
- Founded
- BenevolentAI's press kit lists 2013 as its founding year.checked 14 Nov 2026
- Headquarters
- The company describes itself as headquartered in London.checked 14 Nov 2026
Where it runs
- Platform development
- A 2024 company announcement stated that investment would continue in development of the BenevolentAI Platform.checked 14 Nov 2026
- Platform offering
- BenevolentAI describes its platform as integrating AI and science to uncover new biology, predict novel targets, and develop drugs for complex diseases.checked 14 Nov 2026
Alternatives to Benevolent Platform
- 1
Boltzmann Labs
Free planWebAPI6.7Free plan - 2
Amazon Bio Discovery
Free planWeb6.6From $180 a month - 3
TRION
Free planWebmacOSWindows6.3From $0.01 a month - 46.0Free plan
- 5
StarDrop
WebLinuxmacOSWindows5.7From $10,000 a year - 65.5From $2,500 a month
